A survey on the treatment strategy of patent ductus arteriosus in very low-birth-weight infants

Acta Paediatrica Sinica

Volumn 39, Issue 1, 1998, Pages 33-37

  Su, Bai Horng ^a  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Indomethacin; Patent ductus arteriosus; Very low birth weight infants

Indexed keywords

INDOMETACIN;

ARTICLE; CLINICAL PRACTICE; CLINICAL PROTOCOL; DRUG INDICATION; ECHOCARDIOGRAPHY; GASTROINTESTINAL HEMORRHAGE; HUMAN; HYPOGLYCEMIA; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; NEWBORN; OLIGURIA; ORAL DRUG ADMINISTRATION; PATENT DUCTUS ARTERIOSUS; RESPIRATORY DISTRESS SYNDROME; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; TREATMENT OUTCOME; TREATMENT PLANNING; VERY LOW BIRTH WEIGHT;

DUCTUS ARTERIOSUS, PATENT; FEMALE; HUMANS; INDOMETHACIN; INFANT; INFANT, VERY LOW BIRTH WEIGHT; MALE; RETROSPECTIVE STUDIES;

EID: 0031938343     PISSN: 00016578     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (3)

1. Kaapa P, Seppaen M, Kero P, Saraste M. Pulmonary hemodynamics after synthetic surfactant replacement in neonatal respiratory distress syndrome. J Pediatr 1993; 123:115- 9.
2. Friedman WF, Hirschklau MJ, Printz MP, et al. Pharmacological closure of patent ductus arteriosus in premature infant. N Engl J Med 1976; 295:526-9.
3. Heymann MA, Rudolph AM, Silverman NH. Closure of the ductus arteriosus in premature infants by inhibition of prostaglandin synthesis. N Engl J Med 1976; 295:530-3.